人脐间充质干细胞衍生的外泌体通过芳基烃受体缓解骨破坏并调节骨免疫,从而治疗类风湿性关节炎

IF 4.8 2区 医学 Q2 IMMUNOLOGY International immunopharmacology Pub Date : 2024-10-17 DOI:10.1016/j.intimp.2024.113340
{"title":"人脐间充质干细胞衍生的外泌体通过芳基烃受体缓解骨破坏并调节骨免疫,从而治疗类风湿性关节炎","authors":"","doi":"10.1016/j.intimp.2024.113340","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Rheumatoid arthritis (RA) can lead to joint deformity, loss of function, and even disability. Bone erosion is a common cause of disability in individuals with RA; bone resorption by osteoclasts (OCs) and bone immunity by regulatory T cells (Tregs) play key roles in this process. Human umbilical mesenchymal stem cells (HUMSCs) can be used to treat RA; however, the regulation of Tregs and OCs by HUMSCs and their therapeutic effects on RA have not been fully elucidated. This study aimed to reveal the effects of exosomes derived from HUMSCs carrying miRNA-150-5p on Tregs and OCs in individuals with RA and to provide innovative evidence for the ability of HUMSCs to alleviate RA.</div></div><div><h3>Methods</h3><div>First, we used collagen-induced arthritis (CIA) model mice to verify the efficacy of miR-150-5p<sup>mimic</sup>-Exos and explored their effects on bone erosion in mouse joints and on Tregs in the lymph nodes. Subsequently, miR-150-5p<sup>mimic</sup>-Exos and the aryl hydrocarbon receptor (AhR) inhibitor CH223191 were used in in vitro OCs, Tregs, and OC-Treg coculture systems to determine whether miR-150-5p<sup>mimic</sup>-Exos regulate bone immune microenvironment homeostasis via AhR.</div></div><div><h3>Results</h3><div>Treatment with miR-150-5p<sup>mimic</sup>-Exos effectively alleviated bone damage to the ankle and knee joints in CIA model mice, inhibited OC differentiation, activated the immunosuppressive function of Tregs, and regulated bone immunity by increasing the expression of AhR/CYP1A1 signalling pathway genes such as <em>Ahr, Arnt, Ahrr, Cyp1a1/1a2</em> and <em>Cyp1b1</em> in OCs and Tregs. By coculturing Tregs and OCs, the ability of the miR-150-5p<sup>mimic</sup>-Exos to inhibit OC differentiation was further strengthened.</div></div><div><h3>Conclusions</h3><div>This study confirmed that miR-150-5p<sup>mimic</sup>-Exos can reduce bone destruction in mice with CIA. We first showed that miR-150-5p<sup>mimic</sup>-Exos acted on a Treg-OC coculture system to alleviate bone erosion and regulate bone immunity. This study is expected to provide new ideas for the treatment of RA.</div></div>","PeriodicalId":13859,"journal":{"name":"International immunopharmacology","volume":null,"pages":null},"PeriodicalIF":4.8000,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Human umbilical mesenchymal stem cell-derived exosomes alleviate bone destruction and regulate bone immunity via the aryl hydrocarbon receptor to treat rheumatoid arthritis\",\"authors\":\"\",\"doi\":\"10.1016/j.intimp.2024.113340\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Rheumatoid arthritis (RA) can lead to joint deformity, loss of function, and even disability. Bone erosion is a common cause of disability in individuals with RA; bone resorption by osteoclasts (OCs) and bone immunity by regulatory T cells (Tregs) play key roles in this process. Human umbilical mesenchymal stem cells (HUMSCs) can be used to treat RA; however, the regulation of Tregs and OCs by HUMSCs and their therapeutic effects on RA have not been fully elucidated. This study aimed to reveal the effects of exosomes derived from HUMSCs carrying miRNA-150-5p on Tregs and OCs in individuals with RA and to provide innovative evidence for the ability of HUMSCs to alleviate RA.</div></div><div><h3>Methods</h3><div>First, we used collagen-induced arthritis (CIA) model mice to verify the efficacy of miR-150-5p<sup>mimic</sup>-Exos and explored their effects on bone erosion in mouse joints and on Tregs in the lymph nodes. Subsequently, miR-150-5p<sup>mimic</sup>-Exos and the aryl hydrocarbon receptor (AhR) inhibitor CH223191 were used in in vitro OCs, Tregs, and OC-Treg coculture systems to determine whether miR-150-5p<sup>mimic</sup>-Exos regulate bone immune microenvironment homeostasis via AhR.</div></div><div><h3>Results</h3><div>Treatment with miR-150-5p<sup>mimic</sup>-Exos effectively alleviated bone damage to the ankle and knee joints in CIA model mice, inhibited OC differentiation, activated the immunosuppressive function of Tregs, and regulated bone immunity by increasing the expression of AhR/CYP1A1 signalling pathway genes such as <em>Ahr, Arnt, Ahrr, Cyp1a1/1a2</em> and <em>Cyp1b1</em> in OCs and Tregs. By coculturing Tregs and OCs, the ability of the miR-150-5p<sup>mimic</sup>-Exos to inhibit OC differentiation was further strengthened.</div></div><div><h3>Conclusions</h3><div>This study confirmed that miR-150-5p<sup>mimic</sup>-Exos can reduce bone destruction in mice with CIA. We first showed that miR-150-5p<sup>mimic</sup>-Exos acted on a Treg-OC coculture system to alleviate bone erosion and regulate bone immunity. This study is expected to provide new ideas for the treatment of RA.</div></div>\",\"PeriodicalId\":13859,\"journal\":{\"name\":\"International immunopharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2024-10-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International immunopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1567576924018629\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International immunopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1567576924018629","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的类风湿性关节炎(RA)可导致关节畸形、功能丧失甚至残疾。骨侵蚀是类风湿关节炎患者致残的常见原因;破骨细胞(OCs)的骨吸收和调节性 T 细胞(Tregs)的骨免疫在这一过程中发挥着关键作用。人脐间充质干细胞(HUMSCs)可用于治疗RA;然而,HUMSCs对Tregs和OCs的调控及其对RA的治疗效果尚未完全阐明。本研究旨在揭示携带 miRNA-150-5p 的 HUMSCs 外泌体对 RA 患者 Tregs 和 OCs 的影响,并为 HUMSCs 缓解 RA 的能力提供创新性证据。方法首先,我们使用胶原诱导的关节炎(CIA)模型小鼠验证了 miR-150-5pmimic-Exos 的疗效,并探讨了它们对小鼠关节骨侵蚀和淋巴结中 Tregs 的影响。随后,miR-150-5pmimic-Exos和芳基烃受体(AhR)抑制剂CH223191被用于体外OCs、Tregs和OC-Treg共培养系统,以确定miR-150-5pmimic-Exos是否通过AhR调控骨免疫微环境稳态。结果 miR-150-5pmimic-Exos能有效缓解CIA模型小鼠踝关节和膝关节的骨损伤,抑制OC分化,激活Tregs的免疫抑制功能,并通过增加OC和Tregs中Ahr、Arnt、Ahrr、Cyp1a1/1a2和Cyp1b1等AhR/CYP1A1信号通路基因的表达来调节骨免疫。本研究证实,miR-150-5pmimic-Exos 可减少 CIA 小鼠的骨破坏。我们首次发现,miR-150-5pmimic-Exos 在 Treg-OC 协同培养系统中能减轻骨侵蚀并调节骨免疫。这项研究有望为治疗RA提供新思路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Human umbilical mesenchymal stem cell-derived exosomes alleviate bone destruction and regulate bone immunity via the aryl hydrocarbon receptor to treat rheumatoid arthritis

Objective

Rheumatoid arthritis (RA) can lead to joint deformity, loss of function, and even disability. Bone erosion is a common cause of disability in individuals with RA; bone resorption by osteoclasts (OCs) and bone immunity by regulatory T cells (Tregs) play key roles in this process. Human umbilical mesenchymal stem cells (HUMSCs) can be used to treat RA; however, the regulation of Tregs and OCs by HUMSCs and their therapeutic effects on RA have not been fully elucidated. This study aimed to reveal the effects of exosomes derived from HUMSCs carrying miRNA-150-5p on Tregs and OCs in individuals with RA and to provide innovative evidence for the ability of HUMSCs to alleviate RA.

Methods

First, we used collagen-induced arthritis (CIA) model mice to verify the efficacy of miR-150-5pmimic-Exos and explored their effects on bone erosion in mouse joints and on Tregs in the lymph nodes. Subsequently, miR-150-5pmimic-Exos and the aryl hydrocarbon receptor (AhR) inhibitor CH223191 were used in in vitro OCs, Tregs, and OC-Treg coculture systems to determine whether miR-150-5pmimic-Exos regulate bone immune microenvironment homeostasis via AhR.

Results

Treatment with miR-150-5pmimic-Exos effectively alleviated bone damage to the ankle and knee joints in CIA model mice, inhibited OC differentiation, activated the immunosuppressive function of Tregs, and regulated bone immunity by increasing the expression of AhR/CYP1A1 signalling pathway genes such as Ahr, Arnt, Ahrr, Cyp1a1/1a2 and Cyp1b1 in OCs and Tregs. By coculturing Tregs and OCs, the ability of the miR-150-5pmimic-Exos to inhibit OC differentiation was further strengthened.

Conclusions

This study confirmed that miR-150-5pmimic-Exos can reduce bone destruction in mice with CIA. We first showed that miR-150-5pmimic-Exos acted on a Treg-OC coculture system to alleviate bone erosion and regulate bone immunity. This study is expected to provide new ideas for the treatment of RA.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.40
自引率
3.60%
发文量
935
审稿时长
53 days
期刊介绍: International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome. The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
期刊最新文献
Corrigendum to "Artesunate ameliorates ligature-induced periodontitis by attenuating NLRP3 inflammasome-mediated osteoclastogenesis and enhancing osteogenic differentiation" [Int. Immunopharmacol. 123 (2023) 110749]. Corrigendum to "Human placental mesenchymal stromal cells modulate IFN-γ and IL-10 secretion by CD4+T cells via CD73, and alleviate intestinal damage in mice with graft-versus-host disease" [Int. Immunopharmacol. 124 (2023) 110767]. Corrigendum to "IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling" [Int. Immunopharmacol. 141 (2024) 112966]. Corrigendum to "LncRNA THUMPD3-AS1 enhances the proliferation and inflammatory response of chondrocytes in osteoarthritis" [Int. Immunopharmacol. 100 (2021) 108138]. Corrigendum to "Secretory Nogo-B regulates Th2 differentiation in the lung cancer microenvironment" [Int. Immunopharmacol. 140 (2024) 112763].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1